• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芒柄花黄素通过抑制mTOR信号通路增强依维莫司对乳腺癌MDA-MB-468细胞的杀瘤作用。

Formononetin Enhances the Tumoricidal Effect of Everolimus in Breast Cancer MDA-MB-468 Cells by Suppressing the mTOR Pathway.

作者信息

Zhou Qianmei, Zhang Weihong, Li Tian, Tang Runwei, Li Chaoran, Yuan Shuai, Fan Desheng

机构信息

Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

Breast Surgery Department, Baoshan Branch, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201900, China.

出版信息

Evid Based Complement Alternat Med. 2019 Mar 17;2019:9610629. doi: 10.1155/2019/9610629. eCollection 2019.

DOI:10.1155/2019/9610629
PMID:31007702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6441524/
Abstract

BACKGROUND

Formononetin, an active ingredient isolated from the traditional Chinese medicinal herb , has anticancer and chemoresistance-reducing biological activities. We evaluated the efficacy of formononetin in improving the tumoricidal effect of everolimus by suppressing the mTOR pathway in breast cancer cells.

METHODS

Cell survival was assessed using an MTT assay. Apoptosis was detected using flow cytometry. Proteins related to the mTOR pathway were detected and assessed using real-time PCR and Western blot analysis The results showed that formononetin enhances the efficacy of everolimus in suppressing breast cancer cell growth both in vitro and in vivo. The combination of formononetin and everolimus resulted in a 2-fold decrease in tumor volume and a 21.6% decrease in cell survival. The apoptosis ratio in cells treated with formononetin and everolimus increased by 27.9%. Formononetin and everolimus also inhibited the expression of p-mTOR and p-P70S6K and increased the expression of PTEN and p-4EBP-1. Notably, formononetin alone inhibited p-Akt expression but not everolimus.

CONCLUSIONS

Formononetin enhances the tumoricidal effect of everolimus by inhibiting the activity of Akt.

摘要

背景

芒柄花黄素是从传统中草药中分离出的一种活性成分,具有抗癌和降低化疗耐药性的生物活性。我们评估了芒柄花黄素通过抑制乳腺癌细胞中的mTOR通路来提高依维莫司杀瘤效果的功效。

方法

使用MTT法评估细胞存活率。采用流式细胞术检测细胞凋亡。使用实时PCR和蛋白质免疫印迹分析检测并评估与mTOR通路相关的蛋白质。结果表明,芒柄花黄素在体外和体内均可提高依维莫司抑制乳腺癌细胞生长的功效。芒柄花黄素与依维莫司联合使用可使肿瘤体积减少两倍,细胞存活率降低21.6%。用芒柄花黄素和依维莫司处理的细胞凋亡率增加了27.9%。芒柄花黄素和依维莫司还抑制了p-mTOR和p-P70S6K的表达,并增加了PTEN和p-4EBP-1的表达。值得注意的是,单独使用芒柄花黄素可抑制p-Akt表达,但依维莫司则无此作用。

结论

芒柄花黄素通过抑制Akt活性增强了依维莫司的杀瘤效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01b4/6441524/69f3038bcde9/ECAM2019-9610629.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01b4/6441524/69f3038bcde9/ECAM2019-9610629.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01b4/6441524/69f3038bcde9/ECAM2019-9610629.001.jpg

相似文献

1
Formononetin Enhances the Tumoricidal Effect of Everolimus in Breast Cancer MDA-MB-468 Cells by Suppressing the mTOR Pathway.芒柄花黄素通过抑制mTOR信号通路增强依维莫司对乳腺癌MDA-MB-468细胞的杀瘤作用。
Evid Based Complement Alternat Med. 2019 Mar 17;2019:9610629. doi: 10.1155/2019/9610629. eCollection 2019.
2
Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/AKT/mTOR signaling pathway.从黄芪中提取的物质通过 PI3K/AKT/mTOR 信号通路抑制乳腺癌细胞增殖。
BMC Complement Altern Med. 2018 Mar 9;18(1):83. doi: 10.1186/s12906-018-2148-2.
3
Inhibitory effects of everolimus in combination with paclitaxel on adriamycin-resistant breast cancer cell line MDA-MB-231.依维莫司联合紫杉醇对阿霉素耐药乳腺癌细胞系MDA-MB-231的抑制作用。
Taiwan J Obstet Gynecol. 2020 Nov;59(6):828-834. doi: 10.1016/j.tjog.2020.09.008.
4
Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways.大豆苷元通过PI3K/AKT信号通路抑制基质金属蛋白酶-2(MMP-2)和基质金属蛋白酶-9(MMP-9),从而抑制MDA-MB-231和4T1乳腺癌细胞的迁移和侵袭。
Horm Metab Res. 2014 Oct;46(11):753-60. doi: 10.1055/s-0034-1376977. Epub 2014 Jun 30.
5
[Effects of Astragalus injection and its ingredients on proliferation and Akt phosphorylation of breast cancer cell lines].黄芪注射液及其成分对乳腺癌细胞系增殖及Akt磷酸化的影响
Zhong Xi Yi Jie He Xue Bao. 2009 Dec;7(12):1174-80. doi: 10.3736/jcim20091216.
6
Formononetin, an isoflavone from Astragalus membranaceus inhibits proliferation and metastasis of ovarian cancer cells.芒柄花素,一种来自黄芪的异黄酮,可抑制卵巢癌细胞的增殖和转移。
J Ethnopharmacol. 2018 Jul 15;221:91-99. doi: 10.1016/j.jep.2018.04.014. Epub 2018 Apr 13.
7
Formononetin ameliorates the drug resistance of Taxol resistant triple negative breast cancer by inhibiting autophagy.大豆苷元通过抑制自噬改善紫杉醇耐药三阴性乳腺癌的耐药性。
Am J Transl Res. 2021 Feb 15;13(2):497-514. eCollection 2021.
8
Formononetin inhibits human bladder cancer cell proliferation and invasiveness via regulation of miR-21 and PTEN.大豆苷元通过调控miR-21和PTEN抑制人膀胱癌细胞的增殖和侵袭能力。
Food Funct. 2017 Mar 22;8(3):1061-1066. doi: 10.1039/c6fo01535b.
9
Formononetin promotes cell cycle arrest via downregulation of Akt/Cyclin D1/CDK4 in human prostate cancer cells.大豆苷元通过下调人前列腺癌细胞中的Akt/细胞周期蛋白D1/细胞周期蛋白依赖性激酶4促进细胞周期停滞。
Cell Physiol Biochem. 2014;34(4):1351-8. doi: 10.1159/000366342. Epub 2014 Oct 2.
10
Antitumor effect of the mTOR inhibitor everolimus in combination with trastuzumab on human breast cancer stem cells in vitro and in vivo.mTOR抑制剂依维莫司联合曲妥珠单抗对人乳腺癌干细胞的体内外抗肿瘤作用
Tumour Biol. 2012 Oct;33(5):1349-62. doi: 10.1007/s13277-012-0383-6. Epub 2012 Apr 11.

引用本文的文献

1
Formononetin: a review of its source, pharmacology, drug combination, toxicity, derivatives, and drug delivery systems.芒柄花黄素:来源、药理学、药物联用、毒性、衍生物及药物递送系统综述
Front Pharmacol. 2025 Mar 3;16:1534798. doi: 10.3389/fphar.2025.1534798. eCollection 2025.
2
: A Traditional Chinese Medicine with Multifaceted Impacts on Breast Cancer Treatment.一种对乳腺癌治疗具有多方面影响的中药。
Biomolecules. 2024 Oct 21;14(10):1339. doi: 10.3390/biom14101339.
3
Formononetin triggers ferroptosis in triple-negative breast cancer cells by regulating the mTORC1/SREBP1/SCD1 pathway.

本文引用的文献

1
Aurantoside C Targets and Induces Apoptosis in Triple Negative Breast Cancer Cells.橙皮苷 C 靶向并诱导三阴性乳腺癌细胞凋亡。
Mar Drugs. 2018 Oct 1;16(10):361. doi: 10.3390/md16100361.
2
mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?mTOR 抑制剂治疗与代谢后果:我们处于什么位置?
Oxid Med Cell Longev. 2018 Jun 24;2018:2640342. doi: 10.1155/2018/2640342. eCollection 2018.
3
Differential ability of formononetin to stimulate proliferation of endothelial cells and breast cancer cells via a feedback loop involving MicroRNA-375, RASD1, and ERα.
大豆苷元通过调节mTORC1/SREBP1/SCD1信号通路诱导三阴性乳腺癌细胞发生铁死亡。
Front Pharmacol. 2024 Sep 27;15:1441105. doi: 10.3389/fphar.2024.1441105. eCollection 2024.
4
Tailoring Potential Natural Compounds for the Treatment of Luminal Breast Cancer.定制潜在天然化合物用于治疗管腔型乳腺癌。
Pharmaceuticals (Basel). 2023 Oct 16;16(10):1466. doi: 10.3390/ph16101466.
5
A review of the botany, phytochemistry, traditional uses, pharmacology, toxicology, and quality control of the .对……的植物学、植物化学、传统用途、药理学、毒理学及质量控制的综述。 (你提供的原文不完整,句末缺少关键内容)
Front Pharmacol. 2023 Aug 23;14:1242318. doi: 10.3389/fphar.2023.1242318. eCollection 2023.
6
Potential Therapeutic Targets of Formononetin, a Type of Methoxylated Isoflavone, and Its Role in Cancer Therapy through the Modulation of Signal Transduction Pathways.芒柄花素作为一种甲氧基异黄酮的潜在治疗靶点及其通过调节信号转导通路在癌症治疗中的作用。
Int J Mol Sci. 2023 Jun 3;24(11):9719. doi: 10.3390/ijms24119719.
7
Formononetin: A Pathway to Protect Neurons.大豆苷元:一种保护神经元的途径。
Front Integr Neurosci. 2022 Jul 13;16:908378. doi: 10.3389/fnint.2022.908378. eCollection 2022.
8
Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti-Breast Cancer Therapy.黄酮类化合物靶向癌症中的 mTOR 信号级联:抗乳腺癌治疗中的潜在串扰。
Oxid Med Cell Longev. 2022 Jun 27;2022:4831833. doi: 10.1155/2022/4831833. eCollection 2022.
9
Screening of Immune-Related Genes and Predicting the Immunotherapeutic Effects of Formononetin in Breast Cancer: A Bioinformatics Analysis.免疫相关基因筛选及预测大豆苷元对乳腺癌的免疫治疗效果:一项生物信息学分析
Evid Based Complement Alternat Med. 2022 Apr 15;2022:9942373. doi: 10.1155/2022/9942373. eCollection 2022.
10
Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer.芒柄花黄素缓解长链非编码 RNA AFAP1-AS1- miR-195/miR-545 轴对三阴性乳腺癌进展和化疗耐药的促进作用。
Aging (Albany NY). 2021 Jul 21;13(14):18191-18222. doi: 10.18632/aging.203156.
染料木黄酮通过涉及 MicroRNA-375、RASD1 和 ERα 的反馈环,来差异化刺激内皮细胞和乳腺癌细胞增殖的能力。
Mol Carcinog. 2018 Jul;57(7):817-830. doi: 10.1002/mc.22531. Epub 2018 May 2.
4
Targeted reduction of the EGFR protein, but not inhibition of its kinase activity, induces mitophagy and death of cancer cells through activation of mTORC2 and Akt.靶向降低表皮生长因子受体(EGFR)蛋白,而非抑制其激酶活性,可通过激活哺乳动物雷帕霉素靶蛋白复合物2(mTORC2)和蛋白激酶B(Akt)诱导癌细胞的线粒体自噬和死亡。
Oncogenesis. 2018 Jan 23;7(1):5. doi: 10.1038/s41389-017-0021-7.
5
mTOR function and therapeutic targeting in breast cancer.mTOR在乳腺癌中的功能及治疗靶向作用
Am J Cancer Res. 2017 Mar 1;7(3):383-404. eCollection 2017.
6
mTOR Signaling in Growth, Metabolism, and Disease.生长、代谢及疾病中的mTOR信号传导
Cell. 2017 Mar 9;168(6):960-976. doi: 10.1016/j.cell.2017.02.004.
7
MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.MFN2 通过抑制 mTORC2/Akt 信号通路抑制癌症进展。
Sci Rep. 2017 Feb 8;7:41718. doi: 10.1038/srep41718.
8
Adrenoceptors promote glucose uptake into adipocytes and muscle by an insulin-independent signaling pathway involving mechanistic target of rapamycin complex 2.肾上腺素能受体通过一条涉及雷帕霉素机制靶点复合物2的非胰岛素信号通路促进葡萄糖摄取进入脂肪细胞和肌肉。
Pharmacol Res. 2017 Feb;116:87-92. doi: 10.1016/j.phrs.2016.12.022. Epub 2016 Dec 23.
9
Incidence and Mortality and Epidemiology of Breast Cancer in the World.全球乳腺癌的发病率、死亡率及流行病学
Asian Pac J Cancer Prev. 2016;17(S3):43-6. doi: 10.7314/apjcp.2016.17.s3.43.
10
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.